Biotage ABShs Aktie
| 13,27EUR | 0,47EUR | 3,67% |
WKN DE: A0MNB5 / ISIN: SE0000454746
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 80,47 |
| Gamma Biosciences Newco Ltd. | 16,98 |
| Carnegie Fonder AB | 7,95 |
| Didner & Gerge Småbolag | 5,06 |
| Forsta AP Fonden | 4,87 |
| Invesco Advisers, Inc. | 4,76 |
| SEB Sverige Småbolag Chans/Riskfond | 4,26 |
| Handelsbanken Fonder AB | 4,06 |
| Fjärde AP-fonden | 3,46 |
| Fjarde AP Fonden | 3,27 |
| Swedbank Robur Fonder AB | 3,25 |
| Norges Bank Investment Management | 3,19 |
| Invesco International Small-Mid Company Fund | 3,13 |
| Första AP-fonden | 3,12 |
| Tredje AP-fonden | 2,81 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 464 | 463 | 497 | 517 | 674 |
| Umsatz pro Mitarbeiter in Mio. EUR | 2,37 | 2,36 | 2,48 | 3,03 | 2,76 |
Bilanz (in Mio. SEK) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 587 | 752 | 774 | 1 031 | 1 447 |
| Summe Anlagevermögen | 749 | 683 | 1 218 | 1 308 | 3 484 |
| Summe Aktiva | 1 336 | 1 434 | 1 992 | 2 339 | 4 931 |
Bilanz (in Mio. SEK) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 169 | 214 | 250 | 242 | 627 |
| Summe Fremdkapital | 460 | 444 | 621 | 702 | 1 274 |
| Summe Eigenkapital | 876 | 990 | 1 371 | 1 637 | 3 657 |
| Summe Passiva | 1 336 | 1 434 | 1 992 | 2 339 | 4 931 |
Adresse
| Vimpelgatan 5, 753 18 Uppsala | |
| Telefon | +46 (18) 56-59-00 |
| Fax | +46 (18) 59-19-22 |
| Internet | http://www.biotage.com |
Management
|
Anders Wikström
Executive Vice President-Operations |
|
Andrew F. Kellett
Chief Financial Officer |
|
Daniel Menasco
Director |
|
Frederic Vanderhaegen
President & Chief Executive Officer |
|
Karen Lykke Sörensen
Director |
|
Karen Sørensen
Director |
|
Kieran P. Murphy
Chairman |
|
Kugan Sathiyanandarajah
Director |
|
Lamberstam Philip
Director |
|
Lisa Egelrud
Executive VP-Quality Assurance Regulatory Affairs |
|
Magnus Nordstedt
Executive Vice President-IT & Digitalization |
|
Marc Hummersone
Chief Scientific Officer |
|
Mark Bradley
Director |
|
Maryam Poorafshar
Executive Vice President-Research & Development |
|
Olof Nord
Executive Vice President-Business Development |
|
Peter von Ehrenheim
Director |
|
Petra Duprez
Chief Human Resources & Sustainability Officer |
|
Pär Lundgren
Director |
|
Raffaella Bombarda
Executive Vice President-Global Marketing |
|
Scott Carr
President-Americas |
|
Torben Vedel Stahl Jörgensen
Director |
|
Åsa Hedin
Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
